LONDON, August 29, 2018 /PRNewswire/ --
Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines
The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.3% in the first half of the forecast period. The market is estimated at $12.2bn in 2017 and $14.3bn in 2022.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 256-page report you will receive 97 tables and 100 figures- all unavailable elsewhere.
The 256-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
• Global Allergic Rhinitis Drugs Market forecasts from 2018-2028
• Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2028 for the following submarkets:
• Intranasal Antihistamines
• Intranasal Corticosteroids
• Oral Antihistamines
• Immunotherapy and Vaccines
• How will leading allergic rhinitis drugs perform to 2028 at world level? Our study forecasts individual revenues of these 27 products:
• Alutard SQ
• Generic Azelastine
• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• EU5 - Germany, UK, France, Italy and Spain
• Rest of the World
Each national market is further segmented by submarket.
• Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:
• GlaxoSmithKline (GSK)
• Merck & Co
• Johnson & Johnson
• Kyowo Hako Kirin
• Stallergenes Greer
• This report discusses the trends and development in the allergic rhinitis pipeline
• Our study discusses strengths, weaknesses, opportunities and threats as well as porter's five forces analysis of the global allergic rhinitis drugs market
Visiongain's study is intended for anyone requiring commercial analyses for the global allergic rhinitis drugs market. You find data, trends and predictions.
Buy our report today Global Allergic Rhinitis Drugs Market 2018-2028: Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines.
To request a report overview of this report please contact Sara Peerun at email@example.com or refer to our website : https://www.visiongain.com/report/global-allergic-rhinitis-drugs-market-2018-2028/
Allergy Medical UK
Altana Pharma (Nycomed)
Bausch & Lomb
Catalent Pharma Solutions
Dr Reddy's Laboratories
Hisamitsu Pharmaceutical Co
Human Genome Sciences
Johnson & Johnson
Kyowa Hakko Kirin
Leti Pharma (Laboratorios Leti)
Medpointe Inc (Meda Pharma)
Merck & Co
Mitsubishi Tanabe Pharma
Nippon Paper Group
ProStrakan (Kyowa Hakko Kirin)
Roxane Laboratories (Boehringer Ingelheim)
Shionogi & Co Ltd
Sunovion Pharmaceuticals (Dainippon Sumitomo)
To see a report overview please e-mail Sara Peerun on firstname.lastname@example.org